Literature DB >> 9663472

Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course. LUMINA Study Group. Lupus in minority populations, nature versus nurture.

G S Alarcón1, J Roseman, A A Bartolucci, A W Friedman, J M Moulds, N Goel, K V Straaton, J D Reveille.   

Abstract

OBJECTIVE: To determine the factors associated with disease activity in patients with recent-onset (< or =5 years) systemic lupus erythematosus (SLE) who were of Hispanic, African-American, or Caucasian ethnicity.
METHODS: Incident and prevalent cases of SLE, as defined by the American College of Rheumatology criteria for SLE, among the 3 ethnic groups were identified in Alabama (The University of Alabama at Birmingham) and Texas (The University of Texas-Houston Health Science Center and The University of Texas Medical Branch at Galveston). Variables from the sociodemographic, clinical, immunologic, immunogenetic, behavioral, and psychological domains were obtained using validated instruments. Disease activity was ascertained with the Systemic Lupus Activity Measure (SLAM). Stepwise domain regressions with SLAM score as the dependent variable were performed. Final ethnic-specific and overall regression models were obtained by entering variables that were retained in the domain regressions.
RESULTS: SLAM scores at study entry were higher in the African Americans (mean +/- SD 12.6 +/- 6.9) and Hispanics (11.0 +/- 6.2) than in the Caucasians (8.5 +/- 3.7) (P < or = 0.001). The final overall regression model (R2 = 28%) for higher SLAM score included the following variables: African-American ethnicity, lack of private health insurance, abrupt disease onset, presence of anti-Ro antibodies, absence of HLA-DRB1*0301, higher levels of helplessness, and abnormal illness-related behaviors.
CONCLUSION: Socioeconomic, immunologic, immunogenetic, behavioral, and psychological variables were all predictive of disease activity early in the course of SLE, irrespective of ethnic group. However, there remain ethnic group differences in disease activity that were not explained by these factors.

Entities:  

Mesh:

Year:  1998        PMID: 9663472     DOI: 10.1002/1529-0131(199807)41:7<1173::AID-ART5>3.0.CO;2-A

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  44 in total

1.  Predictors of non-response and non-compliance in African American lupus patients: Findings from the Balancing Lupus Experiences with Stress Strategies (BLESS) Study.

Authors:  Edith M Williams; Jiajia Zhang; Jie Zhou; Diane Kamen; James C Oates
Journal:  Int J Med Biomed Sci       Date:  2014-02

2.  Poverty, not ethnicity, accounts for the differential mortality rates among lupus patients of various ethnic groups.

Authors:  Sergio Durán; Mandar Apte; Graciela S Alarcón
Journal:  J Natl Med Assoc       Date:  2007-10       Impact factor: 1.798

3.  Divergent perceptions in health-related quality of life between family members and patients with rheumatoid arthritis, systemic lupus erythematosus, and ankylosing spondylitis.

Authors:  Cesar Ramos-Remus; José Dionisio Castillo-Ortiz; Carlos Sandoval-Castro; Francisco Paez-Agraz; Adriana Sanchez-Ortiz; Francisco Javier Aceves-Avila
Journal:  Rheumatol Int       Date:  2014-05-24       Impact factor: 2.631

4.  US patients of Hispanic and African ancestry develop lupus nephritis early in the disease course: data from LUMINA, a multiethnic US cohort (LUMINA LXXIV).

Authors:  Paula I Burgos; Gerald McGwin; Guillermo J Pons-Estel; John D Reveille; Graciela S Alarcón; Luis M Vilá
Journal:  Ann Rheum Dis       Date:  2010-07-13       Impact factor: 19.103

5.  Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy.

Authors:  Howard A Austin; Gabor G Illei; Michelle J Braun; James E Balow
Journal:  J Am Soc Nephrol       Date:  2009-03-18       Impact factor: 10.121

6.  Stress Intervention and Disease in African American Lupus Patients: The Balancing Lupus Experiences with Stress Strategies (BLESS) Study.

Authors:  Edith M Williams; Diane Kamen; Megan Penfield; James C Oates
Journal:  Health (Irvine Calif)       Date:  2014-01

7.  Ethnic disparities among patients with systemic lupus erythematosus in South Carolina.

Authors:  Erica Anderson; Paul J Nietert; Diane L Kamen; Gary S Gilkeson
Journal:  J Rheumatol       Date:  2008-03-15       Impact factor: 4.666

8.  Disability in valued life activities among individuals with systemic lupus erythematosus.

Authors:  Patricia Katz; Anne Morris; Laura Trupin; Jinoos Yazdany; Edward Yelin
Journal:  Arthritis Rheum       Date:  2008-04-15

Review 9.  Systemic lupus erythematosus: a therapeutic challenge for the XXI century.

Authors:  Manuel F Ugarte-Gil; Graciela S Alarcón
Journal:  Clin Rheumatol       Date:  2014-02-28       Impact factor: 2.980

10.  Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study.

Authors:  David Isenberg; Gerald B Appel; Gabriel Contreras; Mary A Dooley; Ellen M Ginzler; David Jayne; Jorge Sánchez-Guerrero; David Wofsy; Xueqing Yu; Neil Solomons
Journal:  Rheumatology (Oxford)       Date:  2009-11-20       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.